Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3758 results

Sort By:

Effectiveness of Diabetic Recovery Shoes and Artificial Intelligence Supported Structured Exercise Program

Study ID: NCT06515665
Start Date: 2025-09-30
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

66

Intervention / Treatment

therapeutic foot orthosis

Sponsor

Hacettepe University

Source: clinicaltrials.gov

Share:
Add to list

The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine

Study ID: NCT06853665
Start Date: 2025-08-01
End Date: 2029-04-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

196

Intervention / Treatment

Adderall XR (mixed salts amphetamine)

Placebo

Sponsor

Gagan Joshi

Source: clinicaltrials.gov

Share:
Add to list

Investigating the Impact of Sepsis Phenotypes on Antibiotic Treatment in Patients With Severe Pneumonia and Sepsis

Study ID: NCT06977165
Start Date: 2025-09-01
End Date: 2027-09-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

119

Intervention / Treatment

Antibiotic quantification

Sponsor

University of Manchester

Source: clinicaltrials.gov

Share:
Add to list

HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation

Study ID: NCT06918665
Start Date: 2025-08-01
End Date: 2026-08-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

52

Intervention / Treatment

ivermectin infant formula preparation

Standard ivermectin 3mg tablet

Sponsor

Murdoch Childrens Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Study ID: NCT07007065
Start Date: 2025-09-17
End Date: 2033-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

561

Intervention / Treatment

Surabgene Lomparvovec (ABBV-RGX-314)

Ranibizumab Control

Sponsor

AbbVie

Source: clinicaltrials.gov

Share:
Add to list

Self-Collection for Cervical Cancer Screening and HPV Vaccination for Cancer Prevention Among Women in Emergency Care in Northeast Florida

Study ID: NCT06607874
Start Date: 2025-10-16
End Date: 2026-09-16
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Non-Interventional Study

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Essential Amino Acids and Parkinsons Disease

Study ID: NCT06604065
Start Date: 2026-01
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

15

Intervention / Treatment

AMS2434 (amino acids)

Placebo

Sponsor

University of Arkansas

Source: clinicaltrials.gov

Share:
Add to list

Inflammatory Challenge in Human Aggression.

Study ID: NCT06665074
Start Date: 2025-08-01
End Date: 2030-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

112

Intervention / Treatment

Endotoxin (E. coli O:113, Reference Endotoxin)

Saline (Placebo)

Sponsor

Ohio State University

Source: clinicaltrials.gov

Share:
Add to list

Immediate Implant Placement Utilizing Vestibular Flap Versus Single Flap Approach With Bone Graft

Study ID: NCT06207565
Start Date: 2025-09-01
End Date: 2026-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

34

Intervention / Treatment

Vestibular Flap Group

Single Flap Approach group

Sponsor

Misr International University

Source: clinicaltrials.gov

Share:
Add to list

A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer

Study ID: NCT07060365
Start Date: 2025-07-31
End Date: 2029-04-26
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Saruparib

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list